Royalty Pharma plc
Hedge Funds Holdings
Last updated:
Royalty Pharma plc‘s stocks are currently a part of 263 hedge funds’ portfolios, which represents 64.22% of the total amount of its stocks outstanding. This makes up a total of 266.36M shares of Royalty Pharma plc. Compared to the previous quarter, the number fell by -0.43% or -1.15M shares fewer. As for the holding position changes, 47.15% (124) of current hedge fund investors increased the number of shares held, 22.43% (59) of current holders sold a part of the shares held, and 12.93% (34) closed the holdings completely. 47 hedge funds are new holders of Royalty Pharma plc stock in Q1 2022, it is 17.87% of total holders.
Hedge funds holding Royalty Pharma (Q3 2016 – Q1 2022)
| Q3 2016 | 42 |
|---|---|
| Q4 2016 | 36 |
| Q1 2017 | 30 |
| Q2 2017 | 22 |
| Q3 2017 | 22 |
| Q4 2017 | 23 |
| Q1 2018 | 0 |
| Q1 2019 | 1 |
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 120 |
| Q3 2020 | 130 |
| Q4 2020 | 190 |
| Q1 2021 | 205 |
| Q2 2021 | 224 |
| Q3 2021 | 223 |
| Q4 2021 | 255 |
| Q1 2022 | 263 |
Hedge funds changes in Royalty Pharma positions (Q3 2016 – Q1 2022)
| Q3 2016 | 9 | 7 | 10 | 4 | 12 |
|---|---|---|---|---|---|
| Q4 2016 | 4 | 12 | 6 | 10 | 4 |
| Q1 2017 | 4 | 10 | 5 | 6 | 5 |
| Q2 2017 | 2 | 3 | 11 | 10 | -4 |
| Q3 2017 | 3 | 5 | 7 | 3 | 4 |
| Q4 2017 | 6 | 4 | 7 | 5 | 1 |
| Q1 2018 | 0 | 0 | 0 | 22 | -22 |
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 119 | 0 | 0 | 0 | 1 |
| Q3 2020 | 48 | 47 | 17 | 38 | -20 |
| Q4 2020 | 90 | 67 | 23 | 27 | -17 |
| Q1 2021 | 49 | 82 | 55 | 35 | -16 |
| Q2 2021 | 53 | 89 | 57 | 32 | -7 |
| Q3 2021 | 38 | 85 | 77 | 37 | -14 |
| Q4 2021 | 60 | 107 | 62 | 28 | -2 |
| Q1 2022 | 47 | 124 | 59 | 34 | -1 |
Hedge funds changes in Royalty Pharma stock options (Q3 2016 – Q1 2022)
| Q3 2016 | 1,535,000 | 150,000 |
|---|---|---|
| Q4 2016 | 675,000 | 43,000 |
| Q1 2017 | 575,000 | 0 |
| Q2 2017 | 223,000 | 3,000 |
| Q3 2017 | 94,000 | 0 |
| Q4 2017 | 14,000 | 0 |
| Q1 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 2,631,000 | 1,544,000 |
| Q3 2020 | 5,211,000 | 6,427,000 |
| Q4 2020 | 18,079,000 | 39,419,000 |
| Q1 2021 | 46,536,000 | 34,236,011,429,000 |
| Q2 2021 | 34,617,000 | 34,236,013,785,000 |
| Q3 2021 | 45,453,000 | 6,476,010,609,000 |
| Q4 2021 | 49,106,000 | 11,171,000 |
| Q1 2022 | 39,241,000 | 3,916,000 |